ARCL Organics Board of Directors
Get the latest insights into the leadership at ARCL Organics. Learn about the experienced professionals guiding the company's strategy and governance.
| Name | Position |
|---|---|
| Mr. Suraj Ratan Mundhra | Chairman & Managing Director |
| Mr. Rajesh Mundhra | Executive Director |
| Mr. Brij Mohan Mohta | Ind. Non-Executive Director |
| Mrs. Stuti Pithisaria | Ind. Non-Executive Director |
| Mr. Prateek Chaudhary | Ind. Non-Executive Director |
| Mr. Mukesh Mundra | Executive Director |
ARCL Organics Share price
ARCL
331.15
17.25 (5.50%)Last updated on 4 Sep, 2025 | 15:44 IST
BUYSELL
Today's High
345.25
Today's Low
318.00
52 Week Low
104.20
52 Week High
345.25
The current prices are delayed, login to your account for live prices
LoginARCL Organics FAQs
The board at ARCL Organics consists of experienced professionals, including Mr. Suraj Ratan Mundhra , Mr. Rajesh Mundhra , and others, overseeing the company’s strategic and corporate governance.
Directors at ARCL Organics are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.
As of the latest update, Mr. Suraj Ratan Mundhra is the current chairman at ARCL Organics.
Executive directors at ARCL Organics are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.
Yes, ARCL Organics adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.
At ARCL Organics, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.